Previous 10 | Next 10 |
Combined company will have commercial products and a library of development candidates, two of which are clinical stage Will be under the leadership of DMK CEO, Dr. Ebrahim (Eboo) Versi MD, PhD Lead development program will be a clinical stage therapeutic under development for the...
SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and infla...
Diversifying Your Penny Stocks Portfolio, 3 Tips Diversifying your penny stock portfolio is a key strategy for reducing risk and maximizing returns. By spreading your investments across a range of penny stocks , you can reduce the impact of any individual stock’s performance on you...
Adamis Pharmaceuticals Corporation (ADMP) Q3 2022 Earnings Conference Call November 14, 2022, 17:00 ET Company Participants Robert Uhl - Westwicke Partners David Marguglio - Co-Founder, CEO, President & Director David Benedicto - CFO Conference Call Par...
Adamis Pharmaceuticals press release ( NASDAQ: ADMP ): Q3 GAAP EPS of -$0.03. Revenue of $1.51M (+98.7% Y/Y). Cash and cash equivalents as of September 30, 2022 were approximately $2.4 million. Shares -1.72% AH. For further details see: Adamis Pharmac...
SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inf...
SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it will host an inve...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com We’re starting off the day with an overview of the biggest pre-market stock movers on Tuesday! We’ve got a bankruptcy filing, earnings reports, a reverse stock split, ...
Penny stocks are risky enough. But when you include some of the cheapest of the cheap, be ready to see that risk amplify. Taking out all other contributing factors, the lower the price, the less it takes to realize a significant percentage change in value. Today’s article looks at fo...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com It’s time for another dive into the biggest pre-market stock movers as we check out shares on Wednesday! Moving stocks this morning are clinical trials, special dividend...
News, Short Squeeze, Breakout and More Instantly...
Adamis Pharmaceuticals Corporation Company Name:
ADMP Stock Symbol:
NASDAQ Market:
Adamis Pharmaceuticals Corporation Website:
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK Pharmaceuticals Corporation in order to better reflect its new strategic focus on advancing sm...
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2023, and provided an update on recent corporate developments. Q2 2023 ...
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock (or pre-funded warrant in...